Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce (CELG-RI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CELG-RI · as of Mar 31, 2025
Ownership Breakdown
19
Institutional Holders
$23,544
Total Inst. Value
▼ $22,108 vs Q4
2.04B
Shares Outstanding
freeFloat 99.68%
470,873
13F Shares Held
▼ 460,786 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CELG-RI largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TRANSCEND CAPITAL ADVISORS, LLC pharmaceutical preparations | 109.2K | 0.54% | 0.54% | $5.46M | Apr 24, 2025 | ▼ 8.6K |
DAVENPORT & CO LLC pharmaceutical preparations | 84.0K | 0.41% | 0.41% | $4.20M | Apr 28, 2025 | — held |
MAVEN SECURITIES LTD pharmaceutical preparations | 67.9K | 0.33% | 0.33% | $46.83M | May 14, 2025 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 51.8K | 0.26% | 0.26% | $2.59M | May 15, 2025 | ▲ 180 |
CITADEL ADVISORS LLC pharmaceutical preparations | 36.9K | 0.18% | 0.18% | $1.85M | May 15, 2025 | ▲ 36.9K |
PURKISS CAPITAL ADVISORS LLC pharmaceutical preparations | 26.4K | 0.13% | 0.13% | $1.32M | May 7, 2025 | — held |
TWO SIGMA SECURITIES, LLC pharmaceutical preparations | 25.7K | 0.13% | 0.13% | $1.28M | May 15, 2025 | ▼ 465 |
WATTS GWILLIAM & CO., LLC pharmaceutical preparations | 20.0K | 0.10% | 0.10% | $1.00M | May 13, 2025 | — held |
FIFTH THIRD BANCORP pharmaceutical preparations | 20.0K | 0.10% | 0.10% | $1.00M | Apr 15, 2025 | — held |
PRIVATE ADVISOR GROUP, LLC pharmaceutical preparations | 15.0K | 0.07% | 0.07% | $750,000 | May 5, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
3
Increased
+48.3K shares1
New Positions
first time holders2
Decreased
−9.1K shares2
Sold Out
fully exitedNet shares change (top 50)
+39.2K
+48.3K / −9.1K
Net new holders
+0
1 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CELG-RI insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 24,209 | — | — | 60.9K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 13,906 | — | — | 36.7K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 8,634 | — | — | 22.8K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 18,257 | $88.91 | $1.62M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 18,257 | $71.43 | $1.30M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 613 | — | — | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 26,308 | $100.97 | $2.66M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 3,125 | $114.08 | $356.5K | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 12,906 | $113.18 | $1.46M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 11,384 | $124.06 | $1.41M | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bristol-Myers Squibb Company Ce (CELG-RI) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.32%, while retail and public investors account for the remaining 99.66%.
The largest institutional shareholder of Bristol-Myers Squibb Company Ce is TRANSCEND CAPITAL ADVISORS, LLC, holding approximately 109,175 shares — equal to 0.54% of outstanding shares — as of March 31, 2025.
A total of 19 institutional investors currently hold CELG-RI stock, with a combined institutional value of approximately $23,544 as of the most recent 13F filing period.
Frequently asked questions
CELG-RI ownershipBristol-Myers Squibb Company Ce (CELG-RI) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is TRANSCEND CAPITAL ADVISORS, LLC with a 0.54% stake. Company insiders hold 0.32%. Data sourced from SEC Form 13F as of March 31, 2025.